ÍøºìºÚÁÏ

Skip to main content

R. David Anderson, MD, MS, FACC, FACC, FSCAI, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 15 publications
  • Coronary Artery Disease , 14 publications
  • Coronary Circulation , 10 publications

Research activity

115 publications

7,441 citations

Why is this important?

Active clinical trials

CardiALLO-HF
Investigator
R. David Anderson
Status
Accepting Candidates
PROTECT IV

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All
SMART

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

115 publications

2014

Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.

Circulation research

•

2014

Clinical pharmacogenetics implementation: approaches, successes, and challenges.

American journal of medical genetics. Part C, Seminars in medical genetics

•

2014

Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

International journal of cardiology

•

2014

Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.

Journal of interventional cardiology

•

2014

Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.

American heart journal

•